1. Home
  2. CNDT vs STOK Comparison

CNDT vs STOK Comparison

Compare CNDT & STOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNDT
  • STOK
  • Stock Information
  • Founded
  • CNDT 2016
  • STOK 2014
  • Country
  • CNDT United States
  • STOK United States
  • Employees
  • CNDT N/A
  • STOK N/A
  • Industry
  • CNDT Business Services
  • STOK Biotechnology: Pharmaceutical Preparations
  • Sector
  • CNDT Consumer Discretionary
  • STOK Health Care
  • Exchange
  • CNDT Nasdaq
  • STOK Nasdaq
  • Market Cap
  • CNDT 497.6M
  • STOK 408.8M
  • IPO Year
  • CNDT N/A
  • STOK 2019
  • Fundamental
  • Price
  • CNDT $2.15
  • STOK $9.76
  • Analyst Decision
  • CNDT
  • STOK Strong Buy
  • Analyst Count
  • CNDT 0
  • STOK 6
  • Target Price
  • CNDT N/A
  • STOK $26.00
  • AVG Volume (30 Days)
  • CNDT 1.5M
  • STOK 935.4K
  • Earning Date
  • CNDT 05-07-2025
  • STOK 05-05-2025
  • Dividend Yield
  • CNDT N/A
  • STOK N/A
  • EPS Growth
  • CNDT N/A
  • STOK N/A
  • EPS
  • CNDT 2.23
  • STOK N/A
  • Revenue
  • CNDT $3,356,000,000.00
  • STOK $36,555,000.00
  • Revenue This Year
  • CNDT N/A
  • STOK $27.80
  • Revenue Next Year
  • CNDT $2.28
  • STOK $9.53
  • P/E Ratio
  • CNDT $0.96
  • STOK N/A
  • Revenue Growth
  • CNDT N/A
  • STOK 316.34
  • 52 Week Low
  • CNDT $1.93
  • STOK $5.35
  • 52 Week High
  • CNDT $4.90
  • STOK $17.58
  • Technical
  • Relative Strength Index (RSI)
  • CNDT 32.46
  • STOK 69.57
  • Support Level
  • CNDT $1.93
  • STOK $7.31
  • Resistance Level
  • CNDT $2.16
  • STOK $7.99
  • Average True Range (ATR)
  • CNDT 0.15
  • STOK 0.68
  • MACD
  • CNDT 0.03
  • STOK 0.42
  • Stochastic Oscillator
  • CNDT 36.07
  • STOK 96.80

About CNDT Conduent Incorporated

Conduent Inc acts as a provider of business process services with expertise in transaction-intensive processing, analytics, and automation. The company provides industry-focused service offerings in growth markets such as Healthcare and Transportation as well as provides multi-industry services such as transaction processing, customer care, and payment services. It operates through three segments namely Commercial Industries which is the key revenue-driving segment, Government Services, and Transportation. The group operates its business in the United States, Europe, and Other areas of which the majority of revenue is generated in the United States.

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

Share on Social Networks: